VAERS reports by lot

Moderna COVID-19 lot AS7168B: VAERS reports

164 VAERS reports list lot AS7168B as a Moderna COVID-19 vaccine, received between 2022-12-01 and 2024-12-26. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
164
Reports
8%
Marked serious
2
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)7226%
Cardiac / Cardiovascular5520%
Respiratory3412%
Gastrointestinal3211%
Neurological269%
Dermatological (non-injection-site)155%
Injection-site / Local reaction114%
Thrombotic / Hematological104%
Musculoskeletal93%
Allergic / Anaphylactic83%
Psychiatric / Neuropsychiatric62%
Autoimmune / Immune-mediated41%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida17
Oregon12
California11
Michigan9
Massachusetts7
New York6
Missouri6
Texas6
Tennessee4
Oklahoma3
Arkansas3
Maryland3

Reports by month received

2022-1219
2023-0172
2023-0239
2023-038
2023-042
2023-057
2023-0612
2023-071
2023-082
2023-091
2024-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.